Maravai LifeSciences Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

• Maravai LifeSciences Holdings Inc MRVI.OQ reported a quarterly adjusted loss of 6 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 1 cents. The mean expectation of fifteen analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -6 cents to -2 cents per share.

• Revenue fell 23.7% to $56.56 million from a year ago; analysts expected $57.34 million.

• Maravai LifeSciences Holdings Inc's reported EPS for the quarter was a loss of 18 cents​.

• The company reported a quarterly loss of $25.91 million.

• Maravai LifeSciences Holdings Inc shares had fallen by 51.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 3.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $9.25

This summary was machine generated from LSEG data March 18 at 08:27 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)